|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-2-19
|
|
pubmed:abstractText |
In patients with chronic hepatitis C (HCV) Interferon-alpha (IFN) treatment for 12-18 months is more effective than 6 months in inducing a sustained virological response.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0036-5521
|
|
pubmed:author |
pubmed-author:BrestersDD,
pubmed-author:ChamuleauR ARA,
pubmed-author:CuypersH THT,
pubmed-author:DamenMM,
pubmed-author:HaasHH,
pubmed-author:HermusM CMC,
pubmed-author:LelieP NPN,
pubmed-author:Mauser-BunschotenE PEP,
pubmed-author:ReesinkH WHW,
pubmed-author:SillekensPP,
pubmed-author:WeeginkC JCJ,
pubmed-author:van den BergH MHM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
97-104
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11218246-Adult,
pubmed-meshheading:11218246-Antiviral Agents,
pubmed-meshheading:11218246-Drug Administration Schedule,
pubmed-meshheading:11218246-Female,
pubmed-meshheading:11218246-Hepacivirus,
pubmed-meshheading:11218246-Hepatitis C, Chronic,
pubmed-meshheading:11218246-Humans,
pubmed-meshheading:11218246-Interferon-alpha,
pubmed-meshheading:11218246-Male,
pubmed-meshheading:11218246-RNA, Viral,
pubmed-meshheading:11218246-Recombinant Proteins,
pubmed-meshheading:11218246-Recurrence,
pubmed-meshheading:11218246-Time Factors,
pubmed-meshheading:11218246-Viral Load
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Sustained virological response in chronic hepatitis C patients after a 6- and a 36-month interferon-alpha2b treatment schedule: a multicenter, randomized, controlled study.
|
|
pubmed:affiliation |
Academic Medical Center, Dept of Liver Disease, Amsterdam The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
